4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291) operates in the Medical Devices industry and is headquartered in Shanghai, China with about 370 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 2291 reported CNY 528M in revenue and CNY 240M in net income.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices. It operates through Occluder Business and Heart Valve Business segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 528M | CNY 472M | CNY 327M | CNY 248M | — |
| Gross Profit | CNY 447M | CNY 424M | CNY 289M | CNY 220M | — |
| Operating Income (EBIT) | CNY 259M | CNY 262M | CNY 147M | CNY 78M | — |
| Net Income | CNY 240M | CNY 246M | CNY 151M | (CNY 20M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 215M) | (CNY 195M) | — | — | (CNY 320M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 2.1B | CNY 2.1B | CNY 2.0B | CNY 1.8B | — |
| Total Liabilities | CNY 62M | CNY 86M | CNY 60M | CNY 65M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2291 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms